The coronavirus outbreak has disrupted nearly every industry worldwide, from travel to tech. For nail salons
in particular, it serves as a reminder that disinfection is a critical practice in mitigating the spread of viruses.
To raise awareness and address beauty pros’ concerns, disinfectant manufacturer Virox recently released a statement about the efficacy of its Rejuvenate line of disinfectant concentrate, ready-to-use and premoistened wipes products against coronavirus.

Novel coronavirus, or COVID-19, is an enveloped virus, which is among the easiest organisms for disinfectants to kill or inactivate, the statement explains. But because coronavirus is considered an emerging pathogen, the Environmental Protection Agency (EPA) has not yet approved a testing method for determining or allowing disinfectant efficacy product label claims. In cases like this, however, the EPA implements the Emerging Viral Pathogens Guidance for Antimicrobial Products to identify which products are effective for use against emerging pathogens and to permit registrants to make limited statements pertaining to such pathogens. According to Virox, the following criteria is used to determine the efficacy of a disinfectant upon activation of the emerging pathogen rule:

  1. The product must be a hospital or broad-spectrum  disinfectant registered with the EPA.
  2. For an emerging enveloped virus, the product must have acceptable efficacy data previously submitted to and reviewed by the agency against one nonenveloped virus (poliovirus).

“The Rejuvenate line of products has demonstrated effectiveness against viruses similar to COVID-19 on hard, nonporous surfaces,” the Virox statement reads. “Therefore, the Rejuvenate line of disinfectants can be used against COVID-19 when used in accordance with the directions for use against poliovirus type 1 on hard, nonporous surfaces.” For additional information about coronavirus, visit the Centers for Disease Control and Prevention,

(NAILPRO, MAY/JUNE 2020)  pg 12.